GGrantIndex
Sort

30,917 grants matching tumor microenvironment

C/EBPJ3 in bone marrow stromal cell-mediated drug resistance of multiple myeloma

$263,733
Gangqing Hu · West Virginia University · P20 · FY2022 · GM

Targeting ROS enzymes in myeloid-derived suppressor cell to enhance immunotherapy

$263,733
Tracy W Liu · West Virginia University · P20 · FY2022 · GM

CSF-1R Signaling Pathways Regulating macrophage chemotaxis and angiogenic fac rel

$263,729
E Richard Stanley · Albert Einstein College Of Medicine · P01 · FY2009 · CA

Studies examining quantitative in vivo imaging of breast cancer-targeted, therapeutic human mast cells

$263,686
Chris L Kepley · University Of North Carolina Greensboro · R15 · FY2020 · CA

Role of p62 in metabolic reprograming of the tumor stroma in prostate cancer

$263,682
Maria Teresa Diaz Meco Conde · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA

Advanced Single Cell Technology Innovation Core

$263,678
Peter Alan Sims · Columbia University Health Sciences · U54 · FY2025 · CA

A Phase I Proof-of-Concept Study of CBL0137 Combined with Ipilimumab and Nivolumab Therapy in Locally Advanced or Metastatic Melanoma

$263,670
Igor Astsaturov · Research Inst Of Fox Chase Can Ctr · R21 · FY2023 · CA

Research Project 1: Diffuse Midline Glioma

$263,663
Daphne A. Haas-Kogan · Dana-Farber Cancer Inst · U54 · FY2024 · CA

Integrative Cancer Scholars Training Grant

$263,644
Jennifer S Carew · University Of Arizona · T32 · FY2023 · CA

Cell-Cell & Cell Stroma Regulation in Oral Premalignancy

$263,629
Peter G. Sacks · New York University · R01 · FY2006 · DE

The Role of EphA2 in UV-mediated Apoptosis

$263,625
Hensin Tsao · Massachusetts General Hospital · R21 · FY2008 · ES

Cancer Research Training and Education Coordination

$263,578
Yves A Declerck · University Of Southern California · P30 · FY2023 · CA

The Role of the Stem Cell Niche in ALL

$263,553
Laura F Gibson · West Virginia University · R01 · FY2012 · CA

Project 3: Neoplastic Cell Evolution

$263,539
Darryl K Shibata · Arizona State University-Tempe Campus · U54 · FY2022 · CA

Role of genomic and microenvironment factors in conferring acquired resistance to ferroptosis to chemoradiation in esophageal adenocarcinoma

$263,522
Steven Hsesheng Lin · University Of Tx Md Anderson Can Ctr · U54 · FY2024 · CA

Regulation of Genomic Instability in Early Breast Cancer

$263,486
Thea D Tlsty · University Of California, San Francisco · R01 · FY2010 · CA

Project 2: Targeting Neoantigens for Lung Cancer Immunotherapy

$263,434
Stanley R Riddell · Fred Hutchinson Cancer Research Center · P50 · FY2021 · CA

DNA Damage Targeted Gene Therapy in Head & Neck Cancer

$263,390
Ralph R Weichselbaum · University Of Chicago · R01 · FY2008 · CA

Project 1:Evolutionary dynamics and drivers of breast cancer metastasis and relapse

$263,349
Christina N Curtis · Stanford University · U54 · FY2021 · CA

Project 2: Cellular topography and function of the breast cancer tissue microenvironment

$263,348
Robert Michael Angelo · Stanford University · U54 · FY2021 · CA

Project 3: Systematic characterization of factors controlling breast cancer progression and resistance

$263,348
Michael C Bassik · Stanford University · U54 · FY2021 · CA

Core 2: Stanford Breast Metastasis Center Organoid Core

$263,348
Calvin J Kuo · Stanford University · U54 · FY2021 · CA

Modulation of Microglia and T Cell Interactions in Malignant Glioma

$263,340
Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA

Modulation of Microglia and T Cell Interactions in Malignant Glioma

$263,340
Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA

Modulation of Microglia and T Cell Interactions in Malignant Glioma

$263,340
Amy Beth Heimberger · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA